Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Masoud Farshbaf"'
Autor:
Sunidhi Jaiswal, Saad N Ahmed, Felix B Salazar, Masoud Farshbaf, Bao Y Chen, Jennifer Chean, Kirstin A Zettlitz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0f0f2d590ca8406ca42f47a1f3d8b2e4
Autor:
Mehri Niazi, Parvin Zakeri-Milani, Mehdi Soleymani-Goloujeh, Ali Mohammadi, Muhammad Sarfraz, Raimar Löbenberg, saeedeh Najafi-Hajivar, Javid Shahbazi Mojarrad, Masoud Farshbaf, Hadi Valizadeh
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 24, Iss 3, Pp 383-390 (2021)
Objective(s): Doxorubicin (Dox) is one of the most well-known chemotherapeutics that are commonly applied for a wide range of cancer treatments. However, in most cases, efflux pumps like P-glycoprotein (P-gp), expel the taken drugs out of the cell an
Externí odkaz:
https://doaj.org/article/1b2baeebcf194145b2497083bacb79a7
Autor:
Solmaz Mojarad-Jabali, Somayeh Mahdinloo, Masoud Farshbaf, Muhammad Sarfraz, Yousef Fatahi, Fatemeh Atyabi, Hadi Valizadeh
Publikováno v:
Expert opinion on drug delivery. 19(6)
Compared to normal cells, malignant cancer cells require more iron for their growth and rapid proliferation, which can be supplied by a high expression level of transferrin receptor (TfR). It is well known that the expression of TfR on the tumor cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45f64ea38273d451f217025d8559abf3
https://pubmed.ncbi.nlm.nih.gov/35698794
https://pubmed.ncbi.nlm.nih.gov/35698794
Autor:
Fereshte Rezaie, Masoud Farshbaf, Mohammad Dahri, Moein Masjedi, Reza Maleki, Fatemeh Amini, Jonathan Wirth, Keyvan Moharamzadeh, Franz E. Weber, Lobat Tayebi
Publikováno v:
Journal of Composites Science. 7:80
Revolutionary fabrication technologies such as three-dimensional (3D) printing to develop dental structures are expected to replace traditional methods due to their ability to establish constructs with the required mechanical properties and detailed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::208f761339cab3c8627808f4a22e3162
https://doi.org/10.3390/jcs7020080
https://doi.org/10.3390/jcs7020080
Autor:
Masoud Farshbaf, Solmaz Mojarad-Jabali, Salar Hemmati, Ahmad Yari Khosroushahi, Hamidreza Motasadizadeh, Amir Zarebkohan, Hadi Valizadeh
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 345
The effective treatment of glioma through conventional chemotherapy is proved to be a great challenge in clinics. The main reason is due to the existence of two physiological and pathological barriers respectively including the blood-brain barrier (B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3ef1f0e4d5f3e0d6df359d604307f5e
https://pubmed.ncbi.nlm.nih.gov/35301054
https://pubmed.ncbi.nlm.nih.gov/35301054
Autor:
Mehdi Azizi, Disha Iyengar, Michael R. Hamblin, Arun K. Iyer, Hadi Valizadeh, Mohammad Mehrmohammadi, Roya Salehi, Masoud Farshbaf, Hassan Dianat-Moghadam, Samaresh Sau
Publikováno v:
Adv Funct Mater
Although considerable efforts have been conducted to diagnose, improve, and treat cancer in the past few decades, existing therapeutic options are insufficient, as mortality and morbidity rates remain high. Perhaps the best hope for substantial impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd710299c46678f74d6e40def2829a28
https://pubmed.ncbi.nlm.nih.gov/34093104
https://pubmed.ncbi.nlm.nih.gov/34093104
Autor:
Parvin Zakeri-Milani, Muhammad Sarfraz, Hadi Valizadeh, Salar Hemmati, Paul R. Walker, Yousef Fatahi, Masoud Farshbaf, Solmaz Mojarad-Jabali
Publikováno v:
International journal of pharmaceutics. 602
High-grade glioma is one of the most aggressive types of cancer with a low survival rate ranging from 12 to 15 months after the first diagnosis. Though being the most common strategy for glioma therapy, conventional chemotherapy suffers providing the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369a662e6cfc72e296292e4668555c2e
https://pubmed.ncbi.nlm.nih.gov/33915182
https://pubmed.ncbi.nlm.nih.gov/33915182
Autor:
Javid Shahbazi Mojarrad, Mohammad Reza Mahmoudian, Ali Nokhodchi, Samaneh Mohammadi, Hadi Valizadeh, Samad Mussa Farkhani, Ali Shirani, Parvin Zakeri-Milani, Tooba Gholikhani, Masoud Farshbaf
Publikováno v:
Drug development and industrial pharmacy. 46(4)
The low cellular uptake of Methotrexate (MTX), a commonly used anticancer drug, is a big challenge for efficient cancer therapy. Self-assembled peptide nanoparticles (SAPNs) are one of the major classes of peptide vectors that have gained much attent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f41518e8815495d86e86fa95a7534d2
https://pubmed.ncbi.nlm.nih.gov/32116040
https://pubmed.ncbi.nlm.nih.gov/32116040
Autor:
Hadi Valizadeh, Paul R. Walker, Amir Zarebkohan, Ahmad Yari Khosroushahi, Solmaz Mojarad-Jabali, Masoud Farshbaf
Publikováno v:
Journal of Controlled Release, Vol. 328 (2020) pp. 932-941
As one of the deadliest diseases, cancer frequently resists existing therapeutics because they do not target all cells within a progressing tumor, for example both tumor stem and proliferating cells. This frequently results in enrichment of invasive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36dc25a7cbb48fe60c3934859f46fd25
https://archive-ouverte.unige.ch/unige:148776
https://archive-ouverte.unige.ch/unige:148776
Autor:
Solmaz Mojarad-Jabali, Masoud Farshbaf, Salar Hemmati, Muhammad Sarfraz, Hamidreza Motasadizadeh, Javid Shahbazi Mojarrad, Fatemeh Atyabi, Parvin Zakeri-Milani, Hadi Valizadeh
Publikováno v:
International Journal of Pharmaceutics. 613:121395
The existence of the blood-brain barrier (BBB) makes the clinical chemotherapy of glioma a formidable challenge, because it hinders the passage of different chemotherapeutics into the brain and reduces the overall therapeutic efficiency. Therefore, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cfc283fe5765fc0e5cb044ed00c3e7
https://doi.org/10.1016/j.ijpharm.2021.121395
https://doi.org/10.1016/j.ijpharm.2021.121395